Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms

NCT03855202 is registered in ClinicalTrials.gov with yangjie as lead sponsor.

NCT NCT03855202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03855202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms
Lead sponsor
yangjie
Phase
Phase 1
Overall status
Unknown status
Start date
February 24, 2019
Completion date
August 20, 2020
Enrollment
320 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

neonates premature, ventilator support